No.51
On Jan 2, 2025, all executives received equity grants at $10.71 - the internal fair‑value baseline.
Now, a turning point toward 2026 .
Expected milestone: Phase 2b (NCT06927999)
Primary & study completion: 2026-06 (estimated)
cf. SEC Form 4（Jan 2, 2025）
Total: 2,900.6k @ $10.71
返信
投資の参考になりましたか？
